The Tuberculosis skin test, also known as the Mantoux test, is a widely used method to identify whether a person has been exposed to the bacteria that cause tuberculosis. It is performed by injecting a small amount of purified protein derivative, or PPD, just beneath the surface of the skin, usually on the forearm. This injection produces a small raised area that is observed over the following two to three days. The body’s immune system, if it has previously encountered the tuberculosis bacteria, will react to the PPD by producing a firm swelling at the site of injection. The size of this swelling is carefully measured by a healthcare professional, and the interpretation depends on the individual’s risk factors and medical history. For example, people with weakened immune systems or those who have had close contact with active tuberculosis cases may be considered positive with a smaller reaction, while healthy individuals without risk factors require a larger reaction to be classified as positive.
The test is not perfect, and its limitations must be understood. It cannot distinguish between latent tuberculosis infection, where the bacteria remain dormant in the body, and active tuberculosis disease, which requires immediate treatment. In addition, people who have received the BCG vaccine may show a positive reaction even if they are not infected, and individuals with compromised immune systems may fail to react despite being infected. Because of these limitations, a positive skin test is usually followed by additional examinations such as chest X-rays or laboratory tests to confirm whether the disease is active. A negative test result also does not completely rule out infection, especially in cases of recent exposure or weakened immunity.
Despite these limitations, the Mantoux test remains an important tool in global tuberculosis control programs. It is simple, inexpensive, and can be administered in a wide range of healthcare settings. By identifying individuals with latent infection, it allows for preventive treatment that reduces the risk of developing active disease later in life. This is particularly important in communities where tuberculosis is common, as early detection and treatment can significantly reduce transmission. The test also plays a role in occupational health, especially for healthcare workers and others who may be at increased risk of exposure. In summary, the tuberculosis skin test is a valuable diagnostic method that, when combined with other medical evaluations, helps protect individuals and communities from one of the world’s most persistent infectious diseases.